Ignite Creation Date:
2025-12-24 @ 3:20 PM
Ignite Modification Date:
2026-05-17 @ 10:32 PM
Study NCT ID:
NCT02390492
Status:
COMPLETED
Last Update Posted:
2016-11-02
First Post:
2015-03-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase I Bioavailability and Pharmacokinetic Study of [14C]-Ipatasertib Single Oral and Intravenous Doses in Healthy Male Subjects
Sponsor:
Genentech, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Healthy Volunteer | View |
Keywords: